Paul Callaghan

ETH Zürich is offering a fully funded PhD position in 3D Bioprinting and Tissue Engineering as part of the EU Marie Skłodowska-Curie Actions (MSCA) Print4Life Doctoral Network. The project focuses on developing functional tissue models using advanced bioprinting and microfluidic systems, aiming to address challenges in regenerative medicine and disease modeling. The position is based in the Tissue Engineering and Biofabrication Laboratory led by Prof. Marcy Zenobi-Wong, with co-supervision from Dr. Marcin Kotlarz (ETH Zürich), Prof. Paul Callaghan (Uppsala University), Dr. Maurizio Gullo (University of Applied Sciences Northwestern Switzerland), and Dhayakumar Rajan Prakash (Brinter). The research will involve collaboration with other doctoral students and industry partners, and includes short research stays at Brinter (Finland) and Uppsala University (Sweden). Applicants must have a Master's degree in Biomedical Engineering or a related field, with skills in cell culture, molecular biology, computational fluid dynamics, and bioprinting materials. The MSCA mobility rule applies, and candidates must not have resided in Switzerland for more than 12 months in the past 36 months. The position offers a competitive salary, full tuition coverage, and additional benefits such as public transport, childcare, and pension. The application deadline is December 31, 2025. Applications must be submitted online with a motivation letter, CV, transcripts, and references. For further information, contact Prof. Marcy Zenobi-Wong (no applications via email).